Keith Regnante - 04 Jan 2024 Form 4/A - Amendment Insider Report for Keros Therapeutics, Inc. (KROS)

Signature
/s/ Keith Regnante
Issuer symbol
KROS
Transactions as of
04 Jan 2024
Net transactions value
-$1,171,600
Form type
4/A - Amendment
Filing time
24 Jan 2025, 16:15:08 UTC
Date Of Original Report
08 Jan 2024
Previous filing
08 Jan 2024
Next filing
15 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Options Exercise $640,000 +40,000 $16.00 40,000 04 Jan 2024 Direct F1, F2
transaction KROS Common Stock Sale $1,811,600 -40,000 -100% $45.29 0 04 Jan 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the Date of Earliest Transaction and the Transaction Date of each transaction listed in Table I.
F2 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 8, 2023.